Where Patients Lead: Insights from Frontiers Health 2025

Ultimately, it is patients who are affected by the decisions drugmakers make in bringing, or not bringing, therapies to market. But too often, patients don’t have a voice in that process. 

At Frontiers Health 2025, patient advocate Silvia Cerolini (Eyes on the Future) opened the conference by sharing her story of becoming directly involved in the drug development process in order to bring to market a therapy for her daughter.

In this off-the-stage interview, Cerolini talks about:

• The importance of developing new business models to support rare disease therapies
• Opportunities for savings in clinical development
• Fixing a broken drug development system

Hear from an inspiring change maker and patient advocate in this video from Frontiers Health 2025.